Montefiore AIDS Center Research
A member of the Center for AIDS Research (CFAR), the Montefiore AIDS Center collaborates with Einstein's basic science infectious disease researchers, national HIV clinical trials groups, and pharmaceutical companies to conduct a wide range of clinical trials. Since 2000, the Montefiore AIDS Center has enrolled 150-200 patients each year in integrative research trials, providing access to new HIV medications and new methods of HIV testing and diagnosis.
Montefiore AIDS Center clinical trials include:
- Smoking as an independent predictor of non-adherence in HIV-infected individuals receiving highly active antiretroviral therapy (Shuter)
- Phase I-IV antiretroviral drug studies (Zingman)
Current research initiatives include:
- improving care for HIV-infected patients over 50
- more effective treatment for HIV-positive patients with diabetes
adherence studies examining patients' likelihood and effectiveness in taking HIV/AIDS medication, issues and barriers to taking medication, minimal dosage for effectiveness, likelihood of becoming resistant to the medications, and related public health issues
Einstein-Montefiore faculty physicians regularly publish and present new findings in HIV/AIDS care and research, including numerous abstracts and papers. See faculty listing.